[Federal Register Volume 62, Number 227 (Tuesday, November 25, 1997)]
[Notices]
[Pages 62777-62778]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-31064]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Circulatory System Devices Panel of the Medical Devices Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Circulatory System Devices Panel of the Medical 
Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on December 4, 1997, 8 a.m. 
to 5 p.m.
    Location: Corporate Bldg., conference room 020B, 9200 Corporate 
Blvd., Rockville, MD.
    Contact Person: John E. Stuhlmuller, Center for Devices and 
Radiological Health (HFZ-450), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-443-8243, ext. 157, or FDA 
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
the Washington, DC area), code 12625. Please call the Information Line 
for up-to-date information on this meeting.
    Procedure: On December 4, 1997, from 8 a.m. to 9 a.m., the meeting 
is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues appropriate for 
the committee. Written submissions may be made to the contact person by 
December 3, 1997. Oral presentations from the public will be scheduled 
between 8 a.m. and 9 a.m. Time allotted for each presentation may be 
limited. Those desiring to make formal oral presentations should notify 
the contact person before December 3, 1997, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.

[[Page 62778]]

    FDA regrets that it was unable to publish this notice 15 days prior 
to the December 4, 1997, Circulatory System Devices Panel of the 
Medical Devices Advisory Committee meeting. Because the agency believes 
there is some urgency to bring this issue to public discussion and 
qualified members of the Circulatory System Devices Panel of the 
Medical Devices Advisory Committee were available at this time, the 
Commissioner concluded that it was in the public interest to hold this 
meeting even if there was not sufficient time for the customary 15-day 
public notice.
    Closed Committee Deliberations: On December 4, 1997, from 9 a.m. to 
5 p.m., the meeting will be closed to permit discussion and review of 
trade secret and/or confidential commercial information on a product 
development protocol. This portion of the meeting will be closed to 
permit discussion of this information (5 U.S.C. 552b (c)(4)).
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: November 20, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-31064 Filed 11-21-97; 11:12 am]
BILLING CODE 4160-01-F